Abbott Laboratories (ABT) Long-Term Investments (2009 - 2026)

Abbott Laboratories has disclosed Long-Term Investments across 18 years of filings, most recently posting $1.1 billion for Q2 2026.

• In Q2 2026, Long-Term Investments rose 15.97% year-over-year to $1.1 billion; the TTM figure through Jun 2026 stood at $1.1 billion (up 15.97% YoY), while the FY2025 annual figure was $918.0 million, up 3.61% from the prior year.
• Long-Term Investments came in at $1.1 billion for Q2 2026 at Abbott Laboratories, up from $1.1 billion in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $1.1 billion in Q2 2026 to a low of $734.0 million in Q2 2022.
• Average Long-Term Investments over 5 years is $867.6 million, with a median of $847.5 million recorded in 2024.
• Year-over-year, Long-Term Investments retreated 8.82% in 2022 and climbed 20.18% in 2026.
• Over 5 years, Long-Term Investments stood at $766.0 million in 2022, then increased by 4.31% to $799.0 million in 2023, then gained by 10.89% to $886.0 million in 2024, then increased by 3.61% to $918.0 million in 2025, then increased by 21.02% to $1.1 billion in 2026.
• Per Business Quant data, the three most recent Long-Term Investments figures were $1.1 billion in Q2 2026, $1.1 billion in Q1 2026, and $918.0 million in Q4 2025.